News

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE
NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.
FDA approves Moderna’s next-generation COVID vaccine for adults 65 or older
The FDA approved Novavax’s COVID vaccine Nuvaxovid this month, limiting its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.
Malay Mail5h
US FDA approves Moderna’s next-gen mNEXSPIKE Covid vaccine for adults 65 and older, high-risk individuals
Moderna Covid vaccine approved for those 12-64 with risk factors Moderna expects mNEXSPIKE to be ready for 2025-2026 season ...
NewsX7h
US FDA Approves Moderna’s Next-Generation COVID Vaccine for Older Adults and At-Risk Groups
The US FDA has approved Moderna's next-generation COVID-19 vaccine, mNEXSPIKE, for use in adults aged 65 and older.